Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Pulm Pharmacol Ther ; 55: 75-83, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30776489

RESUMO

Idiopathic pulmonary fibrosis (IPF) is a complex lung disease with incompletely understood pathophysiology. Effectiveness of available medicines is limited and the need for new and improved therapies remains. Due to complexity of the disease, it is difficult to develop predictable in vitro models. In this study we have described precision-cut lung slices (PCLS) prepared from bleomycin treated mice as an in vitro model for testing of novel compounds with antifibrotic activity. We have shown that PCLS during in vitro incubation retain characteristics of bleomycin model with increased expression of fibrosis related genes ACTA2 (α-smooth muscle actin), COL1A1 (collagen 1), FN1 (fibronectin 1), MMP12 (matrix metalloproteinase 12) and TIMP1 (tissue inhibitor of metalloproteinases). To further evaluate PCLS as an in vitro model, we have tested ALK5 inhibitor SB525334 which was previously shown to attenuate fibrosis in in vivo bleomycin model and nintedanib which is the FDA approved treatment for IPF. SB525334 and nintedanib inhibited expression of fibrosis related genes in PCLS from bleomycin treated mice. In addition, comparable activity profile of SB525334 was achieved in PCLS and in vivo model. Altogether these results suggest that PCLS may be a suitable in vitro model for compound testing during drug development process.


Assuntos
Modelos Animais de Doenças , Fibrose Pulmonar Idiopática/fisiopatologia , Imidazóis/farmacologia , Indóis/farmacologia , Quinoxalinas/farmacologia , Animais , Bleomicina/toxicidade , Fibrose Pulmonar Idiopática/tratamento farmacológico , Pulmão/fisiopatologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL
2.
Methods Mol Biol ; 2773: 175-196, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38236546

RESUMO

Necropsy is the postmortem examination of an animal's body. Experiments on laboratory animals are performed to gather scientific data relevant to basic and, even more often, translational research, mainly in the field of translational medicine. A necropsy conducted on laboratory animals subjected to experimental research provides an opportunity to exhaustively explore pathological processes that took place during life. In order to achieve that goal, procedures of biomaterial collection should be performed timely, bearing in mind the inevitable process of postmortem tissue decay, and precisely, to avoid mechanical tissue damage.In this chapter, procedures of collecting organs and tissue in a way that ensures the preservation of the organ structure, tissue organization, morphological characteristics of cells, and last but not least, intracellular protein and nucleic acid content and chromosome organization are going to be described step by step.


Assuntos
Materiais Biocompatíveis , Ácidos Nucleicos , Animais , Camundongos , Autopsia , Empacotamento do DNA , Pesquisa Translacional Biomédica
3.
Pharmacol Res ; 66(4): 332-42, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22749903

RESUMO

Exceptional therapeutic effects of macrolides in treating various infections and inflammatory conditions can be significantly contributed to their unique pharmacokinetic properties. Macrolides accumulate in cells and tissues, with concentrations usually 10 to more than 100 times higher of those measured in plasma. Intracellular distribution of macrolides has so far been examined using extensive subcellular fractionation techniques, radiolabeled compounds and conventional pharmacokinetic methods. In this study we evaluated four fluorescently labeled macrolides on their applicability to monitor azithromycin distribution in vitro and in vivo. 9-Deoxo-9a-{3-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]propyl}-9a-aza-9a-homoerythromycin A (9a-NBD-azithromycin) was selected as a compound with most similar cellular pharmacokinetics to azithromycin. 9a-NBD-azithromycin demonstrated antimicrobial properties comparable to azithromycin, displayed the same biological activity profile in LPS-stimulated J774A.1 murine macrophage cells and, even though it accumulated in cells almost 50% more than azithromycin, it showed same rate of retention. Identical to azithromycin, 9a-NBD-azithromycin was localized in lysosomes of J774A.1 cells. Two hours after 9a-NBD-azithromycin was administered intraperitonally to mice, a strong fluorescent signal was located in kidneys and liver and slightly weaker in the spleen. In kidneys, the signal was concentrated in tubuli, and glomeruli were negative. Patchy florescence in hepatocytes supports lysosomal cellular localization. Weaker staining of white pulp compared to red pulp of spleen is in agreement with lower accumulation of azithromycin in lymphocytes compared to other cell types present. We conclude that 9a-NBD-azithromycin can be used as a fluorescent analog of azithromycin to visualize its distribution in in vitro systems, and is also suitable for in vivo studies.


Assuntos
Antibacterianos/química , Antibacterianos/farmacocinética , Azitromicina/química , Azitromicina/farmacocinética , Corantes Fluorescentes/química , Corantes Fluorescentes/farmacocinética , Animais , Antibacterianos/farmacologia , Azitromicina/farmacologia , Bactérias/efeitos dos fármacos , Infecções Bacterianas/tratamento farmacológico , Linhagem Celular , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Corantes Fluorescentes/farmacologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Testes de Sensibilidade Microbiana , Relação Estrutura-Atividade , Distribuição Tecidual
4.
Toxicol Pathol ; 40(8): 1169-87, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22659244

RESUMO

Smoking-associated chronic obstructive pulmonary disease is characterized by inflammation, changes affecting small airways, and development of emphysema. Various short- and long-term models have been introduced to investigate these processes. The aim of the present study was to identify markers of early epithelial injury/adaptation in a short-term animal model of cigarette smoke exposure. Initially, male BALB/c mice were exposed to smoke from one to five cigarettes and lung changes were assessed 4 and 24 hr after smoking cessation. Subsequently, animals were exposed to smoke from five cigarettes for 2 consecutive days and lungs investigated daily until the seventh postexposure day. Lung homogenates cytokines were determined, bronchioloalveolar fluid cells were counted, and lung tissue was analyzed by immunohistochemistry. Exposure to smoke from a single cigarette induced slight pulmonary neutrophilia. Smoke from two cigarettes additionally induced de novo expression of tight junction protein, claudin-3, by alveolar duct (AD) epithelial cells. Further increases in smoke exposure induced epithelial changes in airway progenitor regions. During the recovery period, the severity/frequency of epithelial reactions slowly decreased, coinciding with the switch from acute to a chronic inflammatory reaction. Claudin-3 and Clara cell 10 kDa protein were identified as possible markers of early tobacco smoke-induced epithelial injury along ADs.


Assuntos
Células Epiteliais Alveolares/efeitos dos fármacos , Claudina-3/metabolismo , Fumar/efeitos adversos , Uteroglobina/metabolismo , Células Epiteliais Alveolares/metabolismo , Células Epiteliais Alveolares/patologia , Animais , Biomarcadores/metabolismo , Líquido da Lavagem Broncoalveolar/química , Líquido da Lavagem Broncoalveolar/citologia , Modelos Animais de Doenças , Exposição por Inalação , Contagem de Leucócitos , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Neutrófilos/efeitos dos fármacos , Neutrófilos/patologia , Fatores de Tempo , Nicotiana , Proteína da Zônula de Oclusão-1/metabolismo
5.
Front Pharmacol ; 12: 682614, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34867313

RESUMO

Claudins are transmembrane proteins constituting one of three tight junction protein families. In patients with inflammatory bowel disease (IBD), disease activity-dependent changes in expression of certain claudins have been noted, thus making certain claudin family members potential therapy targets. A study was undertaken with the aim of exploring expression of claudins in human disease and two different animal models of IBD: dextrane sulfate sodium-induced colitis and adoptive transfer model of colitis. The expression of sealing claudin-1, claudin-3, claudin-4, and claudin-8, and pore-forming claudin-2 in humans and rodents has been evaluated by immunohistochemistry and quantitative polymerase chain reaction. Claudins were expressed by epithelial and cells of mesodermal origin and were found to be situated at the membrane, within the cytoplasm, or within the nuclei. Claudin expression by human mononuclear cells isolated from lamina propria has been confirmed by Western blot and flow cytometry. The claudin expression pattern in uninflamed and inflamed colon varied between species and murine strains. In IBD and both animal models, diverse alterations in claudin expression by epithelial and inflammatory cells were recorded. Tissue mRNA levels for each studied claudin reflected changes within cell lineage and, at the same time, mirrored the ratio between various cell types. Based on the results of the study, it can be concluded that 1) claudins are not expressed exclusively by epithelial cells, but by certain types of cells of mesodermal origin as well; 2) changes in the claudin mRNA level should be interpreted in the context of overall tissue alterations; and 3) both IBD animal models that were analyzed can be used for investigating claudins as a therapy target, respecting their similarities and differences highlighted in this study.

6.
J Pharmacol Exp Ther ; 331(1): 104-13, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19633061

RESUMO

Macrolide antibiotics possess immunomodulatory/anti-inflammatory properties. These properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of chronic inflammatory diseases like diffuse panbronchiolitis and cystic fibrosis. However, the molecular mechanisms and cellular targets of anti-inflammatory/immunomodulatory macrolide activity are still not fully understood. To describe anti-inflammatory effects of macrolides in more detail and to identify potential biomarkers of their activity, we have investigated the influence of azithromycin and clarithromycin on the inflammatory cascade leading to neutrophil infiltration into lungs after intranasal lipopolysaccharide challenge in mice. Azithromycin and clarithromycin pretreatment reduced total cell and neutrophil numbers in bronchoalveolar lavage fluid and myeloperoxidase concentration in lung tissue. In addition, concentrations of several inflammatory mediators, including CCL2, granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-1beta (IL-1beta), tumor necrosis factor alpha, and sE-selectin in lung homogenates were decreased after macrolide treatment. Inhibition of cytokine production observed in vivo was also corroborated in vitro in lipopolysaccharide-stimulated monocytes/macrophages, but not in an epithelial cell line. In summary, results presented in this article confirm that macrolides can suppress neutrophil-dominated pulmonary inflammation and suggest that the effect is mediated through inhibition of GM-CSF and IL-1beta production by alveolar macrophages. Besides GM-CSF and IL-1beta, CCL2 and sE-selectin are also identified as potential biomarkers of macrolide anti-inflammatory activity in the lungs.


Assuntos
Azitromicina/farmacologia , Claritromicina/farmacologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/antagonistas & inibidores , Interleucina-1beta/antagonistas & inibidores , Lipopolissacarídeos/antagonistas & inibidores , Pulmão/efeitos dos fármacos , Pulmão/patologia , Infiltração de Neutrófilos/efeitos dos fármacos , Animais , Linhagem Celular , Fator Estimulador de Colônias de Granulócitos e Macrófagos/biossíntese , Mediadores da Inflamação/antagonistas & inibidores , Mediadores da Inflamação/fisiologia , Mediadores da Inflamação/toxicidade , Interleucina-1beta/fisiologia , Lipopolissacarídeos/toxicidade , Pulmão/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Infiltração de Neutrófilos/fisiologia , Neutrófilos/efeitos dos fármacos , Neutrófilos/patologia , Neutrófilos/fisiologia
7.
Inflamm Res ; 58(11): 773-81, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19440656

RESUMO

OBJECTIVE: To investigate whether challenge with increasing allergen doses could differently affect allergen-induced airway hyperresponsiveness (AHR) and inflammatory cell accumulation in mouse model of asthma, providing an experimental model to investigate their relationship. MATERIAL AND METHODS: AHR and accumulation of inflammatory cells in bronchoalveolar lavage fluid (BALF) and into the lungs were compared in ovalbumin-sensitized mice that were challenged intranasally with 2.5, 10, 25 or 100 microg of ovalbumin/mouse. RESULTS: Both AHR and inflammatory cell accumulation were proportional to the ovalbumin dose used for challenge. However, in group challenged with 10 microg of ovalbumin airway inflammation was present, although allergen-induced AHR was not detected. Additional analysis indicated that neither mucous hyperproduction nor eosinophil degranulation could be correlated to presence of AHR in this model, whereas concentration of interleukin (IL)-13 in BALF was increased only in those groups in which AHR was present. CONCLUSIONS: Altogether, intranasal challenge of mice with increasing allergen doses could serve as a suitable experimental system for investigation of mechanisms by which airway inflammation leads to allergen-induced AHR. Our initial findings are in line with previous reports that dissociate AHR from amount of eosinophil accumulation and imply the role of IL-13 in this process.


Assuntos
Administração Intranasal , Asma/imunologia , Hiper-Reatividade Brônquica , Inflamação/imunologia , Ovalbumina , Animais , Hiper-Reatividade Brônquica/induzido quimicamente , Hiper-Reatividade Brônquica/imunologia , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Citocinas/imunologia , Modelos Animais de Doenças , Peroxidase de Eosinófilo/metabolismo , Eosinófilos/imunologia , Humanos , Interleucina-13/imunologia , Pulmão/citologia , Pulmão/imunologia , Pulmão/patologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Ovalbumina/administração & dosagem , Ovalbumina/imunologia
8.
Toxicol Pathol ; 37(2): 183-92, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19182213

RESUMO

The full-thickness wound in the genetically diabetic (db/db) mouse is a commonly used model of impaired wound healing. We investigated delayed healing of non-occluded, excisional, full-thickness, dermal wounds in db/db mice in comparison to their normal littermate controls and refined methods for monitoring skin wound re-epithelialization, contraction, granulation tissue formation, and inflammation. We have confirmed with a computer-assisted planimetry method the results of previous studies showing that healing of non-occluded full excision wounds in db/db mice does not occur by contraction as much as in healthy mice. In addition, we have developed separate histological methods for the assessment of re-epithelialization, contraction, granulation tissue (mature, immature, fibrosis), and inflammation (lipogranulomas, secondary, nonspecific). Using a new approach to histological assessment, we have shown that wound closure in db/db mice is delayed owing to: (1) delayed granulation tissue maturation; (2) ''laced,'' widely distributed granulation tissue around fat lobules; and (3) obstruction by lipogranulomas, whereas the rate of re-epithelialization seems to be the same as in C57Bl/6 mice. This methodology should permit a more precise differentiation of effects of novel therapeutic agents on the wound healing process in db/db mice.


Assuntos
Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Pele/lesões , Cicatrização/fisiologia , Ferimentos Penetrantes/patologia , Animais , Feminino , Fibrose/patologia , Tecido de Granulação/patologia , Inflamação/patologia , Camundongos , Camundongos Endogâmicos C57BL , Pele/patologia , Ferimentos Penetrantes/etiologia
10.
Eur J Pharmacol ; 570(1-3): 212-21, 2007 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-17628536

RESUMO

Apart from becaplermin (recombinant human platelet-derived growth factor homodimer of B chains, PDGF-BB), for the treatment of lower extremity diabetic ulcers, few agents are available for pharmacological stimulation of wound healing. We have compared the mechanism of action of the potential wound healing agent, PL 14736 (G E P P P G K P A D D A G L V), with that of PDGF-BB on granulation tissue formation following sponge implantation in the normoglycemic rat and in healing full-thickness excisional wounds in db/db genetically diabetic mice. Expression of the immediate response gene, early growth response gene-1 (egr-1) was studied in Caco-2 cells in vitro. While PDGF-BB and PL 14736 had similar selectivity for stimulation of granulation tissue in both sponge granuloma and in healing wounds in db/db mice, PL 14736 was more active in stimulating early collagen organization. It also stimulated expression of egr-1 and its repressor nerve growth factor 1-A binding protein-2 (nab2) in non-differentiated Caco-2 cells more rapidly than PDGF-BB. EGR-1 induces cytokine and growth factor generation and early extracellular matrix (collagen) formation, offering an explanation for the beneficial effects of PL 14736 on wound healing.


Assuntos
Colágeno/metabolismo , Proteína 1 de Resposta de Crescimento Precoce/metabolismo , Tecido de Granulação/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Proteínas/farmacologia , Cicatrização/efeitos dos fármacos , Animais , Becaplermina , Células CACO-2 , Citocinas/metabolismo , Diabetes Mellitus/genética , Diabetes Mellitus/metabolismo , Diabetes Mellitus/patologia , Diabetes Mellitus/fisiopatologia , Proteína 1 de Resposta de Crescimento Precoce/genética , Tecido de Granulação/metabolismo , Tecido de Granulação/patologia , Granuloma de Corpo Estranho/tratamento farmacológico , Granuloma de Corpo Estranho/metabolismo , Granuloma de Corpo Estranho/patologia , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Fragmentos de Peptídeos/uso terapêutico , Fator de Crescimento Derivado de Plaquetas/farmacologia , Proteínas/uso terapêutico , Proteínas Proto-Oncogênicas c-sis , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Proteínas Recombinantes/farmacologia , Proteínas Repressoras/genética
11.
Int Immunopharmacol ; 7(12): 1544-51, 2007 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-17920531

RESUMO

Serum amyloid A protein (SAA) is an acute phase protein, known to be a sensitive indicator of inflammation. We have characterized the time course of the SAA response and inflammatory reaction to silver nitrate injection s.c. in mice and studied the effects of dexamethasone and macrolide antibiotics. 2% Sterile silver nitrate solution was injected s.c. into female BALB/c mice and blood collected by capillary action from the tail vein of each mouse at different time points. Hematological variables were determined, albumin by spectrophotometry and SAA and cytokines by ELISA. Animals were treated with either a single i.p. dose of dexamethasone (5-30 mg/kg) 1 h after or daily oral doses of macrolide antibiotics for 3 days. SAA concentrations after silver nitrate injection peaked at 24 h, preceded by increases in serum IL-1 beta and IL-6, associated with decreases in blood leukocytes and local tissue inflammation. Single dexamethasone treatment and daily dosing for 3 days with azithromycin, clarithromycin and roxithromycin (20-80 mg/kg p.o.), but not erythromycin (100-150 mg/kg p.o.), inhibited the increase in SAA but with varying time courses. SAA, measured continuously, is a useful marker of sterile inflammation in mice and is differentially inhibited by macrolide antibiotics.


Assuntos
Antibacterianos/farmacologia , Dexametasona/farmacologia , Macrolídeos/farmacologia , Proteína Amiloide A Sérica/metabolismo , Nitrato de Prata/farmacologia , Reação de Fase Aguda/sangue , Reação de Fase Aguda/induzido quimicamente , Reação de Fase Aguda/prevenção & controle , Animais , Anti-Inflamatórios/farmacologia , Azitromicina/farmacologia , Contagem de Células , Claritromicina/farmacologia , Feminino , Inflamação/sangue , Inflamação/induzido quimicamente , Inflamação/prevenção & controle , Interleucina-1beta/sangue , Interleucina-6/sangue , Contagem de Leucócitos , Camundongos , Camundongos Endogâmicos BALB C , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/patologia , Neutrófilos/citologia , Neutrófilos/efeitos dos fármacos , Contagem de Plaquetas , Roxitromicina/farmacologia , Gordura Subcutânea/efeitos dos fármacos , Gordura Subcutânea/patologia
12.
Eur J Pharmacol ; 517(1-2): 132-43, 2005 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-15964564

RESUMO

The anti-inflammatory potential of azithromycin in chronic obstructive pulmonary disease (COPD) patients was explored following a standard oral dosing regimen. Patients with moderate and severe COPD were treated with azithromycin (500 mg, n=16) or placebo (n=8) once daily for 3 days in a randomized, double blind design, to compare effects on inflammation markers with those seen in a previous study in healthy volunteers. A battery of tests was made on serum, blood neutrophils and sputum on days 1 (baseline), 3, 4, 11, 18 and 32. In comparison to placebo, azithromycin resulted in an early transient increase in serum nitrites plus nitrates (day 3), associated with a tendency towards an increase in the blood neutrophil oxidative burst to phorbol myristic acetate. Subsequently, prolonged decreases in blood leukocyte and platelet counts, serum acute phase protein (including C reactive protein) and soluble E-selectin and blood neutrophil lactoferrin concentrations and a transient decrease in serum interleukin-8 were observed. Blood neutrophil glutathione peroxidase activity showed a prolonged increase after azithromycin treatment. The biphasic facilitatory-then-inhibitory response to azithromycin seen in healthy volunteers is not so clearly detectable in COPD patients, only potential anti-inflammatory effects. Treatment for longer periods may give therapeutic anti-inflammatory benefit in these patients.


Assuntos
Azitromicina/uso terapêutico , Inflamação/tratamento farmacológico , Neutrófilos/efeitos dos fármacos , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Adulto , Idoso , Anti-Inflamatórios/uso terapêutico , Biomarcadores/sangue , Contagem de Células Sanguíneas , Proteína C-Reativa/metabolismo , Contagem de Células , Método Duplo-Cego , Selectina E/sangue , Glutationa/sangue , Glutationa Peroxidase/sangue , Fator Estimulador de Colônias de Granulócitos e Macrófagos/sangue , Granulócitos/efeitos dos fármacos , Granulócitos/fisiologia , Humanos , Inflamação/sangue , Interleucina-6/sangue , Interleucina-8/sangue , Lactoferrina/sangue , Masculino , Pessoa de Meia-Idade , Neutrófilos/metabolismo , Nitratos/sangue , Nitritos/sangue , Projetos Piloto , Doença Pulmonar Obstrutiva Crônica/sangue , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Explosão Respiratória/efeitos dos fármacos , Testes de Função Respiratória , Proteína Amiloide A Sérica/metabolismo , Escarro/citologia , Escarro/efeitos dos fármacos , Fatores de Tempo , Resultado do Tratamento , Fator de Necrose Tumoral alfa/metabolismo
13.
Arh Hig Rada Toksikol ; 55(4): 243-8, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15584550

RESUMO

The aim of our study was to find whether ochratoxin A (OTA) induces the apoptosis and/or necrosis of kidney tissue in rats. In the first experiment, the highest number of apoptotic cells was found in rats sacrificed one day after OTA administration (1.00 mg/kg b.w., i.p.). The number of apoptotic cells reduced gradually and they were not seen nine days after OTA administration. A possible dose-dependence of histological changes was checked in kidney tissue of rats given 0.25, 0.50 or 1.00 mg of OTA/kg b.w., i.p. three times a week for four weeks. The number of apoptotic cells showed a clear dose-dependence, but necrosis was absent even at the highest doses. The time-dependent appearance of lesions related to OTA administration was checked by administering 0.50 mg OTA/kg body weight to rats, and sacrificing them one day after 1, 3, 6, and 9 doses/administrations, or 6 and 21 day after 12 doses/administrations. Long-term administration is associated with continued and increased apoptosis without necrosis, suggestive of OTA's role in the pathogenesis of progressive renal atrophy.


Assuntos
Apoptose/efeitos dos fármacos , Carcinógenos/toxicidade , Rim/efeitos dos fármacos , Ocratoxinas/toxicidade , Animais , Relação Dose-Resposta a Droga , Feminino , Rim/patologia , Ratos , Ratos Wistar
14.
Inflammation ; 35(1): 192-205, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21336676

RESUMO

Macrolide antibiotics inhibit the secretion of Th1 cytokines while their effects on the release of Th2 cytokines are variable. We investigated molecular and cellular markers of Th1- and Th2-mediated inflammatory mechanisms and the anti-inflammatory activity of azithromycin and clarithromycin in phorbol 12-myristate 13-acetate (PMA) and oxazolone (OXA)-induced skin inflammation. Dexamethasone (50 µg/ear), azithromycin, and clarithromycin (500 µg/ear) reduced TNF-α and interleukin (IL)-1ß concentration in ear tissue by inhibiting inflammatory cell accumulation in PMA-induced inflammation. In OXA-induced early delayed-type hypersensitivity (DTH), the macrolides (2 mg/ear) and dexamethasone (25 µg/ear) reduced ear tissue inflammatory cell infiltration and secretion of IL-4 while clarithromycin also decreased IFN-γ concentration. Macrolides showed better activity when administered after the challenge. In OXA-induced chronic DTH, azithromycin (1 mg/ear) reduced the number of ear tissue mast cells and decreased the concentration of IL-4 in ear tissue and of immunoglobulin (Ig)E in serum. Clarithromycin (1 mg/ear) reduced serum IgE concentration, possibly by a mechanism independent of IL-4, while both macrolides attenuated mast cell degranulation. In conclusion, azithromycin and clarithromycin attenuate pro-inflammatory cytokine production and leukocyte infiltration during innate immune reactions, while selectively affecting Th2 rather than Th1 immunity in DTH reactions.


Assuntos
Azitromicina/administração & dosagem , Claritromicina/administração & dosagem , Dermatite de Contato/tratamento farmacológico , Hipersensibilidade Tardia/tratamento farmacológico , Células Th2/imunologia , Administração Tópica , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Azitromicina/uso terapêutico , Degranulação Celular/efeitos dos fármacos , Claritromicina/uso terapêutico , Dermatite de Contato/imunologia , Dexametasona/administração & dosagem , Dexametasona/uso terapêutico , Orelha , Hipersensibilidade Tardia/imunologia , Imunoglobulina E/sangue , Interferon gama/biossíntese , Interleucina-1beta/biossíntese , Interleucina-4/metabolismo , Mastócitos/efeitos dos fármacos , Mastócitos/imunologia , Camundongos , Oxazolona , Pele/imunologia , Pele/patologia , Acetato de Tetradecanoilforbol , Células Th2/efeitos dos fármacos , Fator de Necrose Tumoral alfa/biossíntese
15.
J Leukoc Biol ; 91(2): 229-43, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22131344

RESUMO

Azithromycin, a macrolide antibacterial, has been shown to modify the phenotype of macrophages. We have investigated whether azithromycin in vitro is able to modulate the differentiation of human blood monocytes to DCs. iA-DCs appear to have a unique phenotype, characterized by increased granularity, adherence, and a surface molecule expression profile similar to that of MDCs, namely, CD1a⁻CD14⁻CD71⁺CD209(high), as well as high CD86 and HLA-DR expression. The iA-DC phenotype is associated with increased IL-6 and IL-10 release, increased CCL2 and CCL18 expression and release, and M-CSF expression, as well as reduced CCL17 expression and release. Upon maturation with LPS, A-DCs and MDCs exhibit decreased expression of HLA-DR and costimulatory molecules, CD40 and CD83, as well as an increase in IL-10 and a decrease in CCL17 and CXCL11 secretion. These modulated responses of iA-DCs were associated with the ability to reduce a MLR, together with enhanced phagocytic and efferocytotic properties. Azithromycin, added 2 h before activation of iDCs with LPS, enhanced IL-10 release and inhibited IL-6, IL-12p40, CXCL10, CXCL11, and CCL22 release. In conclusion, azithromycin modulates the differentiation of blood monocyte-derived DCs to form iA-DCs with a distinct phenotype similar to that of iMDCs, accompanied by enhanced phagocytic and efferocytic capabilities. It also modifies LPS-induced DC maturation by decreasing surface molecule expression required for T cell activation, increasing IL-10 production, and inducing MLR-reducing properties.


Assuntos
Azitromicina/farmacologia , Células Dendríticas/citologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Interleucina-4/farmacologia , Monócitos/efeitos dos fármacos , Apoptose , Autofagia , Diferenciação Celular/efeitos dos fármacos , Separação Celular/métodos , Células Cultivadas/efeitos dos fármacos , Células Dendríticas/imunologia , Regulação da Expressão Gênica , Humanos , Imunofenotipagem , Células Jurkat , Teste de Cultura Mista de Linfócitos , Fator Estimulador de Colônias de Macrófagos/farmacologia , Monócitos/citologia , Fagocitose , RNA Mensageiro/biossíntese , Reação em Cadeia da Polimerase em Tempo Real , Linfócitos T/imunologia
16.
Transl Res ; 160(2): 137-45, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22677362

RESUMO

The murine model of cantharidin-induced ear inflammation was profiled in detail for its alignment with the human model and to explore the mechanism of anti-inflammatory activity of the macrolide antibiotics, clarithromycin and azithromycin. Ear swelling in CD1 mice persisted for 7 days, with peak intensity at 16 h after inflammation induction. As in humans, cantharidin (12.5 µg/ear) generated macrophage-inflammatory protein (MIP)-2, monocyte chemoattractant protein (MCP)-1, keratinocyte-derived chemokine (KC), interleukin (IL)-6, IL-1ß, and myeloperoxidase (MPO) production, as well as neutrophil accumulation in mouse ear tissue. The tested macrolides, clarithromycin and azithromycin, administered orally (2 × 150 mg/kg) 0.5 h before and 5 h after cantharidin challenge, reduced MIP-2, MCP-1, KC, and MPO concentrations and thereby decreased ear swelling. Our results suggest that cantharidin-induced acute inflammation represents an excellent model for translational research of novel anti-inflammatories.


Assuntos
Anti-Inflamatórios/farmacologia , Cantaridina/toxicidade , Modelos Animais de Doenças , Orelha Externa/efeitos dos fármacos , Camundongos Endogâmicos , Otite Externa , Administração Tópica , Animais , Antibacterianos/farmacologia , Azitromicina/farmacologia , Cantaridina/administração & dosagem , Claritromicina/farmacologia , Relação Dose-Resposta a Droga , Orelha Externa/imunologia , Orelha Externa/patologia , Edema/induzido quimicamente , Edema/tratamento farmacológico , Edema/imunologia , Irritantes/administração & dosagem , Irritantes/toxicidade , Masculino , Camundongos , Otite Externa/induzido quimicamente , Otite Externa/tratamento farmacológico , Otite Externa/imunologia , Pesquisa Translacional Biomédica/métodos
17.
Inflammation ; 34(5): 471-86, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20872058

RESUMO

Inflammatory and antioxidant responses, in male C57Bl6J mice, to single intranasal inoculations with live or heat-killed Streptococcus pneumoniae were studied in order to tease out differences in responses. Heat-killed bacteria elicited weak lung neutrophil infiltration and raised concentrations (peak 6-8 h), in serum or lung tissue, of CXCL1 and 2, tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), and granulocyte-macrophage-colony stimulating factor, with later increases in CCL2 and IL-1ß. Live bacteria induced profound pulmonary neutrophil infiltration and acute chemokine/cytokine elevations. After 72-96 h, live S. pneumoniae induced a delayed rise in chemokines CXCL2 and CCL2, preceded by increases in TNFα, IL-1ß, and IL-6 and mononuclear infiltration of lungs. With both live and heat-killed bacteria, alveolar epithelial type II cells and alveolar macrophages were the main sources of TNFα and IL-1ß. Only live bacteria caused an acute decrease in lung glutathione peroxidase, an increase in superoxide dismutase, and a sustained increase in serum amyloid protein A. Acute innate immune responses to live and heat-killed S. pneumoniae are similar. In response to live bacteria, inflammation is greater, accompanied by changes in antioxidant enzymes and has an additional, later mononuclear component.


Assuntos
Antioxidantes/metabolismo , Mediadores da Inflamação/metabolismo , Pneumonia Pneumocócica/metabolismo , Streptococcus pneumoniae/patogenicidade , Animais , Carga Bacteriana , Quimiocina CXCL1/metabolismo , Quimiocina CXCL2/metabolismo , Citocinas/metabolismo , Glutationa Peroxidase/metabolismo , Temperatura Alta , Imunidade Inata , Interleucina-6/metabolismo , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/microbiologia , Pulmão/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/microbiologia , Pneumonia Pneumocócica/patologia , Streptococcus pneumoniae/imunologia , Superóxido Dismutase/metabolismo
18.
Int Immunopharmacol ; 11(4): 424-34, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21195124

RESUMO

Macrolide antibiotics, including azithromycin, also possess anti-inflammatory properties. However, the molecular mechanism(s) of activity as well as the target cells for their action have not been unambiguously identified as yet. In this study, the effects of azithromycin on lipopolysaccharide (LPS)-induced pulmonary neutrophilia were investigated in mice. Using immunohistochemistry, mRNA and specific protein assays, we confirmed that azithromycin ameliorates LPS-induced pulmonary neutrophilia by inhibiting interleukin-1ß (IL-1ß) expression and production selectively in alveolar macrophages as well as in LPS-stimulated J774.2 macrophage-derived cells in vitro. Inhibition by azithromycin of neutrophilia and IL-1ß was accompanied by prevention of nuclear expression of activator protein-1 (AP-1) in both alveolar macrophages and J774.2 cells. The macrolide did not alter nuclear factor kappa B (NF-κB) or extracellular signal-regulated kinase 1/2 (ERK1/2) expression, activation or localization in LPS-stimulated lungs or in J774.2 cells. In conclusion, we have shown that inhibition of LPS-induced pulmonary neutrophilia and IL-1ß concentrations in lung tissue following azithromycin treatment is mediated through effects on alveolar macrophages. In addition, we have shown for the first time, in an in vivo model, that azithromycin inhibits AP-1 activation in alveolar macrophages, an action confirmed on J774.2 cells in vitro.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Azitromicina/farmacologia , Interleucina-1beta/biossíntese , Pulmão/imunologia , Infiltração de Neutrófilos/efeitos dos fármacos , Fator de Transcrição AP-1/antagonistas & inibidores , Animais , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Linhagem Celular , Ensaio de Imunoadsorção Enzimática , MAP Quinases Reguladas por Sinal Extracelular/imunologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Imuno-Histoquímica , Interleucina-1beta/imunologia , Lipopolissacarídeos/toxicidade , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , NF-kappa B/imunologia , NF-kappa B/metabolismo , Infiltração de Neutrófilos/imunologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA